The brain-computer interface device received CE marking for adults with severe central vision loss caused by geographic atrophy due to dry age-related macular degeneration.

Prima is intended for individuals whose central vision loss has previously restricted their ability to read or recognise ...

Science describes PRIMA as an "investigational" retinal implant designed to combat vision loss caused by GA and AMD. For the time being, the device is commercially ...

Precision Neuroscience Corporation (Precision), a leader in brain–computer interface (BCI) technology, announced the appointment of John Donoghue, Ph.D., as Scientific Advisor. Donoghue, Professor ...

AndroGuider is a blog where you can scoop your daily need of tech information with some dose of special reviews and custom ...

A groundbreaking brain implant has helped a paralyzed man regain movement and the sensation of touch years after a spinal ...

"The thing that the space needs is a company making $100 million a year of revenue," Science Corp. CEO Max Hodak said.

As BCIs move from laboratories towards commercial use, unequal access could separate people not only by income or connectivity, but by physical and cognitive capability.

The Prima implant [Image courtesy of Science Corporation] Science Corporation today announced the European commercial launch of its Prima brain-computer interface (BCI) implant for vision restoration.

Science Corp. Announces European Commercial Launch of PRIMA, the Only Treatment to Restore Functional Central Vision to Patients with Geographic Atrophy Caused by Age-Related Macular Degeneration, a ...

Summary: Researchers introduced the world’s first chip capable of matching the operational speed of the human brain. Fabricated using a standard 40-nanometer process, the sub-10-millisecond neural ...